299. Cystic fibrosis Clinical trials / Disease details

Clinical trials : 1,695 / Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

5 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00803179 (ClinicalTrials.gov)	November 2008	4/12/2008	Growth Hormone Therapy for Wasting in Cystic Fibrosis	Growth Hormone Therapy for Wasting in Cystic Fibrosis	Cystic Fibrosis	Drug: Nutropin AQ	University of Massachusetts, Worcester	NULL	Terminated	18 Years	N/A	All	5	Phase 1	United States
2	NCT00287430 (ClinicalTrials.gov)	January 2006	2/2/2006	Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis		Cystic Fibrosis	Drug: Growth Hormone;Procedure: Whole body Protein Turnover Study;Procedure: Dual Energy X-ray Absorptiometry (DEXA)	University of Texas Southwestern Medical Center	Dana S Hardin	Withdrawn	6 Years	40 Years	All	0	N/A	NULL
3	NCT00016445 (ClinicalTrials.gov)	February 2001	6/5/2001	Phase II Study of Growth Hormone in Children With Cystic Fibrosis		Cystic Fibrosis	Drug: growth hormone	University of Utah	NULL	Completed	5 Years	12 Years	Both	40	Phase 2	United States
4	NCT00005112 (ClinicalTrials.gov)	April 2000	15/4/2000	Growth Hormone Use in Cystic Fibrosis - a Multicenter Study		Cystic Fibrosis	Drug: Human recombinant growth hormone	National Center for Research Resources (NCRR)	Genentech, Inc.	Completed	5 Years	12 Years	Both		Phase 3	United States
5	NCT00256555 (ClinicalTrials.gov)	February 2000	17/11/2005	Growth Hormone Treatment Study in Children With Cystic Fibrosis	GROWTH HORMONE USE IN CYSTIC FIBROSIS - A MULTICENTER STUDY	Cystic Fibrosis	Drug: Nutropin AQ	University of Texas Southwestern Medical Center	Genentech, Inc.	Withdrawn	5 Years	12 Years	All	0	Phase 2/Phase 3	NULL